Dietary interventions can improve clinical outcomes for some women with breast cancer
the ONA take:
Data from the Women’s Intervention Nutrition Study (WINS) presented at the San Antonio Breast Cancer Symposium demonstrated that reducing dietary intake of fat reduces death rates in some women with early stage breast cancer.
The WINS was a randomized trial, to which 2,437 women ages 48 to 79 years were recruited. The women had early stage hormone-unrelated breast cancer, receiving standard-of-care treatments at 39 centers in the United States. They were randomly assigned to follow a dietary intervention that reduced their fat intake for 5 years following diagnosis (975 patients) or to a control group (1,462 patients).
Centrally trained, registered dietitians implemented the low-fat eating plan via eight biweekly individual counseling sessions and subsequent contacts every 3 weeks, plus unannounced 24-hour telephone recalls performed annually. In addition, the women self-monitored and recorded their fat intake in a book. After more than 15 years of follow-up, death rates from all causes in the intervention group were significantly lower than in the control group.
“The dietary intervention was supported for a median of 5 years,” the researchers reported. Based on their findings, however, the researchers suggest that for lifestyle interventions to have a long-term influence on clinical outcomes, they must be lifelong changes rather than short-term interventions.
Reducing dietary intake of fat reduces death rates in some women with early stage breast cancer.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Robotic Surgery Provides Good Outcomes and Survival in Oropharyngeal Cancer
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- Ruxolitinib Effective as Long-term Treatment Option for Polycythemia Vera
- Definitive IMRT Associated With Shorter Feeding Tube Placement Duration in HNC
- SBRT Improves Overall and Disease-Specific Survival in Stage I NSCLC
- Patients Receiving RT in APBI Facilities Despite Eligibility for Observation
- Prolonged Imatinib Therapy Improves Likelihood of Deeper Molecular Response
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|